Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
12:00:00 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5,639.00 JPY | -0.07% |
|
-5.53% | +16.63% |
| 30/09 | Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading | MT |
| 30/09 | Takeda Reports New Psoriasis Treatment Outperformed Competitor in Phase 3 Trial | MT |
| Market Cap | 9,00400Cr 5.7TCr 5.08TCr 4.74TCr 4.31TCr 8.12TCr 5,48800Cr 8.18TCr 57TCr 22TCr 2,80100Cr 21TCr 21TCr | P/E 2027 * |
44.6x | P/E 2028 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise Value | 12,91100Cr 8.17TCr 7.29TCr 6.79TCr 6.18TCr 12TCr 7,87000Cr 12TCr 82TCr 32TCr 4,01700Cr 31TCr 30TCr | EV / Sales 2027 * |
2.74x | EV / Sales 2028 * | 2.65x |
| Free-Float |
99.25% | Yield 2027 * |
3.62% | Yield 2028 * | 3.7% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
Tradegate
| TKD | Real-time | |
OTC Markets
| TKPHF | Delayed | |
Deutsche Boerse AG
| TKD | Delayed | |
Boerse Muenchen
| TKD | Real-time | |
Börse Stuttgart
| TKD | Delayed | |
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -0.07% | ||
| 1 week | -5.53% | ||
| Current month | -2.44% | ||
| 1 month | -1.98% | ||
| 3 months | +5.22% | ||
| 6 months | -2.81% | ||
| Current year | +16.63% |
| 1 week | 5,606 | 5,868 | |
| 1 month | 5,557 | 6,030 | |
| Current year | 4,710 | 6,033 | |
| 1 year | 4,102 | 6,033 | |
| 3 years | 3,852 | 6,033 | |
| 5 years | 2,993 | 6,033 | |
| 10 years | 2,894.5 | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 61 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/09/26 | Sell | Executive/Senior Manager | -34,535 | 0.0022% | ||
| 02/09/26 | Sell | Chief Technology Officer | -1,16,191 | 0.0073% | ||
| 19/08/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | -5.53% | +32.43% | +29.57% | 5.71TCr | ||
| +1.09% | -2.58% | +36.59% | +113.17% | 1,01900Cr | ||
| -0.77% | -6.68% | +34.87% | +61.50% | 62TCr | ||
| +0.38% | -0.91% | +14.62% | +78.94% | 46TCr | ||
| -2.79% | -5.66% | +57.97% | +35.40% | 36TCr | ||
| +0.93% | -1.83% | +20.98% | +41.43% | 33TCr | ||
| +0.12% | -4.05% | +10.09% | +33.53% | 27TCr | ||
| -0.89% | -5.83% | -7.56% | +7.91% | 24TCr | ||
| +0.08% | -3.59% | +37.06% | +52.08% | 22TCr | ||
| -0.31% | -5.20% | +27.05% | +93.17% | 18TCr | ||
| Average | -0.30% | -3.73% | +26.41% | +54.67% | 37.54TCr | |
| Weighted average by Cap. | -0.09% | -3.57% | +28.99% | +68.44% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,70400Cr 2.98TCr 2.66TCr 2.47TCr 2.25TCr 4.24TCr 2,86700Cr 4.27TCr 30TCr 12TCr 1,46300Cr 11TCr 11TCr | 4,79400Cr 3.03TCr 2.71TCr 2.52TCr 2.3TCr 4.32TCr 2,92200Cr 4.35TCr 30TCr 12TCr 1,49100Cr 11TCr 11TCr |
| Net income | 20TCr 124.37Cr 110.95Cr 103.36Cr 94Cr 177.14Cr 12TCr 178.45Cr 1.25TCr 485.93Cr 6.11TCr 466.87Cr 456.8Cr | 32TCr 204.26Cr 182.22Cr 169.76Cr 154.49Cr 290.94Cr 20TCr 293.09Cr 2.05TCr 798.08Cr 10TCr 766.79Cr 750.25Cr |
| Net Debt | 3,90700Cr 2.47TCr 2.21TCr 2.05TCr 1.87TCr 3.52TCr 2,38100Cr 3.55TCr 25TCr 9.66TCr 1,21500Cr 9.28TCr 9.08TCr | 3,70200Cr 2.34TCr 2.09TCr 1.95TCr 1.77TCr 3.34TCr 2,25700Cr 3.36TCr 24TCr 9.16TCr 1,15200Cr 8.8TCr 8.61TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | JP¥5,639.00 | -0.07% | 32,69,900 |
| 02/26/02 | JP¥5,643.00 | -1.54% | 42,17,900 |
| 01/26/01 | JP¥5,731.00 | -0.85% | 42,31,700 |
| 30/26/30 | JP¥5,780.00 | +0.71% | 52,43,000 |
| 29/26/29 | JP¥5,739.00 | -3.22% | 48,44,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions


















